This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capilla, J.
Right arrow Articles by Guarro, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capilla, J.
Right arrow Articles by Guarro, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2004, p. 4009-4011, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.4009-4011.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Correlation between In Vitro Susceptibility of Scedosporium apiospermum to Voriconazole and In Vivo Outcome of Scedosporiosis in Guinea Pigs

Javier Capilla and Josep Guarro*

Unitat de Microbiologia Facultat de Medicina, Universitat Rovira i Virgili, Reus, Spain

Received 1 September 2003/ Returned for modification 15 October 2003/ Accepted 28 May 2004

We have evaluated the efficacy of voriconazole (VRC) in a systemic infection by Scedosporium apiospermum in immunodepressed guinea pigs. Animals were infected with two strains; one required a VRC MIC of 0.5 to 1 µg/ml, common for this fungus, and the other required a high MIC (8 µg/ml), unusual in this species. VRC prolonged survival and reduced fungal load in kidney and brain tissues of the animals infected with the first strain but was unable to prolong survival or to reduce fungal load in brain tissue for the latter strain.


* Corresponding author. Mailing address: Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, Spain. Phone: 977 759359. Fax: 977 759322. E-mail: jga{at}fmcs.urv.es.


Antimicrobial Agents and Chemotherapy, October 2004, p. 4009-4011, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.4009-4011.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Troke, P., Aguirrebengoa, K., Arteaga, C., Ellis, D., Heath, C. H., Lutsar, I., Rovira, M., Nguyen, Q., Slavin, M., Chen, S. C. A., on behalf of the Global Scedosporium Study Group, (2008). Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients. Antimicrob. Agents Chemother. 52: 1743-1750 [Abstract] [Full Text]  
  • Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., Rinaldi, M. G., Shea, Y. R., Zaoutis, T., Kottilil, S., Walsh, T. J. (2008). Infections Caused by Scedosporium spp.. Clin. Microbiol. Rev. 21: 157-197 [Abstract] [Full Text]  
  • Gilgado, F., Serena, C., Cano, J., Gene, J., Guarro, J. (2006). Antifungal Susceptibilities of the Species of the Pseudallescheria boydii Complex. Antimicrob. Agents Chemother. 50: 4211-4213 [Abstract] [Full Text]  
  • Gilgado, F., Cano, J., Gene, J., Guarro, J. (2005). Molecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New Species. J. Clin. Microbiol. 43: 4930-4942 [Abstract] [Full Text]  
  • Yustes, C., Guarro, J. (2005). In Vitro Synergistic Interaction between Amphotericin B and Micafungin against Scedosporium spp.. Antimicrob. Agents Chemother. 49: 3498-3500 [Abstract] [Full Text]